发明名称 TUBULAR PROTEINURIA AS AN INDICATOR FOR ELEVATED CARDIOVASCULAR RISK
摘要 The invention relates to the use of an ACE inhibitor or an angiotensin receptor antagonist for the preparation of a pharmaceutical composition for reducing tubular proteinuria oral/or alpha1-microglubulin in a non-diabetic human individual for reducing the risk of a cardiovascular event.
申请公布号 KR20060110306(A) 申请公布日期 2006.10.24
申请号 KR20067010325 申请日期 2006.05.26
申请人 SANOFI-AVENTIS DEUTSCHLAND GMBH 发明人 SCHRADER JOACHIM
分类号 A61K31/4184;A61K31/40;A61K31/403;A61K31/41;A61K31/415;A61K31/4178 主分类号 A61K31/4184
代理机构 代理人
主权项
地址